People · Operator
Named in public records as an officer, director or promoter · active 2010–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ridge Diagnostics, Inc. | — | Biotechnology | Series A | $7.4M | $9.0M | 2010 |
David A. Vandertie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David A. Vandertie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David F Hale | 1 | 16 |
| Charles J. Cashion | 1 | 2 |
| Stan F. Sewitch | 1 | 2 |
| Gregory M. Decker | 1 | 1 |
| Karen A. Klause | 1 | 1 |
| Lonna J. Williams | 1 | 1 |
| Ancelmo A. Lopes | 1 | 1 |
| John A. Bilello, Ph.D. | 1 | 1 |
| Bo A. Pi, Ph.D. | 1 | 1 |
| Perry A. Renshaw, M.D., Ph.D. | 1 | 1 |
| John J. Bilello | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.